Search research articles
Contact Us
Filters
Showing results (51-60 of 317) with videos related to
Page
of 32
Sort By:
Journal of Neurology
|
October 5, 2017
Disease reactivation after switching from natalizumab to daclizumab
Timo Uphaus, Christoph Oberwittler, Sergiu Groppa, et al.
Med (New York, N.Y.)
|
May 26, 2023
Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis
Aaron Schuckmann, Falk Steffen, Frauke Zipp, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 19, 2013
How to treat tumefactive demyelinating disease?
Volker Siffrin, Wibke Müller-Forell, Harald von Pein, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 21, 2018
GFAPα IgG-associated encephalitis upon daclizumab treatment of MS
Felix Luessi, Sinah Engel, Annette Spreer, et al.
Trends in Neurosciences
|
February 16, 2010
Multiple sclerosis - candidate mechanisms underlying CNS atrophy
Volker Siffrin, Johannes Vogt, Helena Radbruch, et al.
Journal of Neuroscience Methods
|
December 19, 2006
High-field diffusion tensor imaging of mouse brain in vivo using single-shot STEAM MRI
Susann Boretius, Jens Würfel, Frauke Zipp, et al.
The Thoracic and Cardiovascular Surgeon
|
June 26, 2014
Long-term performance of the bovine pericardium patch in conventional carotid endarterectomy
Bernhard Dorweiler, Charlotte Kayser, Frauke Zipp, et al.
Nature Medicine
|
January 10, 2012
The problems and promises of research into human immunology and autoimmune disease
Bart O Roep, Jane Buckner, Stephen Sawcer, et al.
Archives of Neurology
|
February 14, 2007
Neuronal damage in brain inflammation
Orhan Aktas, Oliver Ullrich, Carmen Infante-Duarte, et al.
Brain : a Journal of Neurology
|
June 28, 2021
The potential of serum neurofilament as biomarker for multiple sclerosis
Stefan Bittner, Jiwon Oh, Eva Kubala Havrdová, et al.
Page
of 32
Search research articles
Search
Showing results (51-60 of 317) with videos related to
Sort By:
Page
of 32
Journal of Neurology
|
October 5, 2017
Disease reactivation after switching from natalizumab to daclizumab
Timo Uphaus, Christoph Oberwittler, Sergiu Groppa, et al.
Med (New York, N.Y.)
|
May 26, 2023
Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis
Aaron Schuckmann, Falk Steffen, Frauke Zipp, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 19, 2013
How to treat tumefactive demyelinating disease?
Volker Siffrin, Wibke Müller-Forell, Harald von Pein, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 21, 2018
GFAPα IgG-associated encephalitis upon daclizumab treatment of MS
Felix Luessi, Sinah Engel, Annette Spreer, et al.
Trends in Neurosciences
|
February 16, 2010
Multiple sclerosis - candidate mechanisms underlying CNS atrophy
Volker Siffrin, Johannes Vogt, Helena Radbruch, et al.
Journal of Neuroscience Methods
|
December 19, 2006
High-field diffusion tensor imaging of mouse brain in vivo using single-shot STEAM MRI
Susann Boretius, Jens Würfel, Frauke Zipp, et al.
The Thoracic and Cardiovascular Surgeon
|
June 26, 2014
Long-term performance of the bovine pericardium patch in conventional carotid endarterectomy
Bernhard Dorweiler, Charlotte Kayser, Frauke Zipp, et al.
Nature Medicine
|
January 10, 2012
The problems and promises of research into human immunology and autoimmune disease
Bart O Roep, Jane Buckner, Stephen Sawcer, et al.
Archives of Neurology
|
February 14, 2007
Neuronal damage in brain inflammation
Orhan Aktas, Oliver Ullrich, Carmen Infante-Duarte, et al.
Brain : a Journal of Neurology
|
June 28, 2021
The potential of serum neurofilament as biomarker for multiple sclerosis
Stefan Bittner, Jiwon Oh, Eva Kubala Havrdová, et al.
Page
of 32